Search

Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus treatment with sunitinib (Sutent®) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) that were reported online today in the New England Journal of Medicine.

… Wednesday, March 21, 2018 Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) significantly increased overall survival versus treatment with sunitinib (Sutent ® ) alone, according to new findings from researchers

Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer care.

… Tuesday, August 4, 2015 Memorial Sloan Kettering Cancer Center (MSK) and Lehigh Valley Health Network (LVHN) announced today the beginning of a unique and forward-thinking collaboration aimed at improving patient access to the latest and most effective cancer treatment advances and highest-caliber cancer

Dana Pe’er, PhD, computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today.

… Thursday, September 23, 2021 Dana Pe’er, PhD , computational biologist and lab head at Memorial Sloan Kettering Cancer Center’s (MSK) Sloan Kettering Institute (SKI), is one of 33 biomedical researchers named a Howard Hughes Medical Institute (HHMI) investigator today. The elite group of scientists,

An enzyme that contributes to plaque formation in the brain also serves as a first line of defense against bacteria and viruses, suggesting a link between the two.

… Wednesday, September 2, 2020 Summary Scientists at the Sloan Kettering Institute have discovered a direct link between the immune response to viruses and bacteria and the development of plaques in the brain that characterize Alzheimer’s disease. Alzheimer’s disease is a neurodegenerative condition that

Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it.

… Friday, July 11, 2014 Summary Memorial Sloan Kettering’s vision is nothing less than to revolutionize the treatment of cancer. Learn about some of the ways we’re doing it. The word “transformation” perfectly characterizes and captures the past year at Memorial Sloan Kettering. Indeed, it’s the word we

Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change.

… Thursday, January 27, 2022 Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change. Dave Linn and Jennifer Goodman Linn used their experience with

Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives.

… Monday, October 24, 2022 Patients with inoperable advanced liver cancer have a new option for treatment to extend their lives. Today the U.S. Food and Drug Administration (FDA) approved a combination of the immunotherapy drugs durvalumab (Imfinzi®) plus the experimental drug tremelimumab for people with

MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation. MSK Kids has been ranked by U.S. News & World Report for the past 12 years.

… Tuesday, June 16, 2020 MSK Kids , the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK) has been named one of the best children’s hospitals nationally, according to U.S. News & World Report in its annual “Best Children’s Hospitals” list. MSK Kids is ranked 13th in the nation.

A new resource provides a comprehensive list of human proteins that could trigger autoimmune symptoms in ‘long COVID’ patients.

… Monday, May 24, 2021 Approximately 10% of people who contract COVID-19 will develop lingering symptoms — fever, fatigue, blood clots, or brain fog — that can last for months. The underlying cause of “long COVID” is not yet known, but one hypothesis is autoimmune reactions. An autoimmune reaction occurs

Discover how MSK Kids is using medical play to help children understand treatments and procedures.

… Thursday, December 5, 2019 Summary Medical play is an important component of care at MSK Kids. Learn how child life specialists teach young children and prepare them for their treatments. A hospital can be an unnerving place for anyone, regardless of age. But for children, the environment may be totally